| 0 (0%) | 02-21 14:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.49  |
1-year : | 14.83 |
| Resists | First : | 11.55 |
Second : | 12.69 |
| Pivot price | 10.56 |
|||
| Supports | First : | 9.69 |
Second : | 8.07 |
| MAs | MA(5) : | 10.67 |
MA(20) : | 10.82 |
| MA(100) : | 11.17 |
MA(250) : | 9.5 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 72.8 |
D(3) : | 49.1 |
| RSI | RSI(14): 55.4 |
|||
| 52-week | High : | 14.93 | Low : | 3.89 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ORIC ] has closed below upper band by 18.4%. Bollinger Bands are 43.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 11.36 - 11.41 | 11.41 - 11.46 |
| Low: | 10.67 - 10.73 | 10.73 - 10.77 |
| Close: | 11.01 - 11.12 | 11.12 - 11.19 |
Fri, 20 Feb 2026
Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Thu, 19 Feb 2026
Oric Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Mon, 16 Feb 2026
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sun, 15 Feb 2026
(ORIC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Sat, 14 Feb 2026
$ORIC Q4 2025 Earnings Preview: Recent $ORIC Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Fri, 06 Feb 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 97 (M) |
| Shares Float | 64 (M) |
| Held by Insiders | 6.7 (%) |
| Held by Institutions | 107.7 (%) |
| Shares Short | 21,140 (K) |
| Shares Short P.Month | 17,960 (K) |
| EPS | -1.72 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.17 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -25.3 % |
| Return on Equity (ttm) | -39.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -117 (M) |
| Levered Free Cash Flow | -71 (M) |
| PE Ratio | -6.5 |
| PEG Ratio | 0 |
| Price to Book value | 2.65 |
| Price to Sales | 0 |
| Price to Cash Flow | -9.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|